Top News
Latest News
INNOVATION
12 Dec 2025
CRISPR Breakthrough Brings Gene Editing Closer to Daily CareTECHNOLOGY
10 Dec 2025
AI Turbocharges Metagenomi’s CRISPR QuestINSIGHTS
24 Nov 2025
Lipid Cuts, Big Deals, and a New CRISPR EraINNOVATION
19 Nov 2025
CRISPR GPT Sparks a Faster Era in Biotech Research
Can a New Pact Propel Gene Editing Into Its Next Era?
INVESTMENT
17 Nov 2025
AstraZeneca and Algen team up on gene editing and AI to tackle immune diseases
PARTNERSHIPS
11 Nov 2025
RNA Alliance: CRISPR and Sirius Redefine Precision Therapy
A CRISPR–Sirius alliance aims to advance siRNA therapies for safer clot prevention
RESEARCH
7 Nov 2025
Can a Single Gene Edit Stop Heart Disease?
Lilly’s Verve deal propels research into lasting genetic fixes for cholesterol
REGULATORY
6 Nov 2025
FDA Puts Intellia’s CRISPR Trials Under the Microscope
FDA’s hold on Intellia’s MAGNITUDE trials marks a sharper focus on CRISPR safety and long-term risk tracking
PARTNERSHIPS
4 Nov 2025
AstraZeneca’s AI-CRISPR Gamble Could Rewrite Drug Discovery
A $555m pact with Algen Biotechnologies marries AI and CRISPR to speed drug discovery in immune diseases
INNOVATION
31 Oct 2025
CRISPR Pushes Closer to One-Shot Genetic Cures
CRISPR’s CTX460 shows strong AATD results, edging gene therapy closer to one-shot cures
TECHNOLOGY
29 Oct 2025
Coding the Cure: Lilly and Verve Team Up on Gene Editing
The $1.3 billion Verve deal expands Lilly’s reach into gene editing and next-generation heart therapies
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.